Curza is a company headquartered in the United States.
Curza is a therapeutics company developing novel small-molecule antibiotics targeting drug-resistant bacterial infections, including ESKAPE pathogens and biofilm-related infections.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.